Literature DB >> 8666438

Bovine gamma/delta T-cell proliferation is associated with self-derived molecules constitutively expressed in vivo on mononuclear phagocytes.

A J Okragly1, M Hanby-Flarida, D Mann, C L Baldwin.   

Abstract

Bovine gamma/delta T cells have been shown previously to proliferate when cocultured with gamma-irradiated bovine monocytes in the 'autologous mixed leucocyte reaction' (AMLR). It was suggested that the response may be to culture-derived or culture-induced antigenic epitopes. Data presented here indicate that the gamma/delta T-cell stimulatory activity is attributable to a self-derived cell-surface molecule of mononuclear phagocytes that is constitutively expressed in vivo. The ability to induce an AMLR did not require in vitro culture or stress associated with in vitro isolation of cells or increased temperature since it could be induced by monocytes fixed by paraformaldehyde during blood collection from normal animals. Furthermore, stimulation by monocytes did not depend upon secreted molecules since fixed monocytes that had been incubated overnight at 37 degrees to allow secretion of preformed molecules, or subjected to hypotonic shock in H2O for 10 min before addition to the cultures, induced an AMLR as did plasma membranes prepared from ex vivo monocytes. In contrast, enzymatic treatment of monocytes to digest surface molecules followed by fixation destroyed their ability to stimulate an AMLR. The ability of monocytes to stimulate proliferation of gamma/delta T cells was distinguishable from their ability to stimulate alpha/beta T cells, since the former was destroyed by glutaraldehyde fixation whereas stimulation of alpha/beta T cells by major histocompatibility complex (MHC)-presented antigenic epitopes is not. Moreover, induction of proliferation of bovine gamma/delta T cells was not MHC-restricted. Finally, bovine alveolar macrophages, sheep monocytes and transformed bovine monocytes stimulated proliferation of bovine gamma/delta T cells whereas none of the following did so: human monocytes, murine macrophages, bovine myeloid cells other than mononuclear phagocytes, other nucleated cells found in bovine blood including activated MHC class II-bearing B cells, and a variety of species of bacteria. Thus, the stimulatory epitope is unique to and conserved among mononuclear phagocytes of ruminants. Demonstration of stimulation of bovine gamma/delta T cells by self-derived molecules is consistent with reports for murine gamma/delta T cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666438      PMCID: PMC1383970     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  Preferential activation of peripheral blood V gamma 9+ gamma/delta T cells by group A, B and C but not group D or F streptococci.

Authors:  A Bender; D Kabelitz
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 2.  Potential developmental role for self-reactive T cells bearing gamma-delta T cell receptors specific for heat-shock proteins.

Authors:  D A Ferrick; L Gemmell-Hori
Journal:  Chem Immunol       Date:  1992

Review 3.  Function of autoreactive T cells in immune responses.

Authors:  A Finnegan; B W Needleman; R J Hodes
Journal:  Immunol Rev       Date:  1990-08       Impact factor: 12.988

Review 4.  The role of gamma delta T lymphocytes in infection.

Authors:  W K Born; K Harshan; R L Modlin; R L O'Brien
Journal:  Curr Opin Immunol       Date:  1991-08       Impact factor: 7.486

5.  Surface expression by mononuclear phagocytes of an epitope shared with mycobacterial heat shock protein 60.

Authors:  A Wand-Württenberger; B Schoel; J Ivanyi; S H Kaufmann
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

6.  A lectin-binding, protease-resistant mycobacterial ligand specifically activates V gamma 9+ human gamma delta T cells.

Authors:  K Pfeffer; B Schoel; N Plesnila; G B Lipford; S Kromer; K Deusch; H Wagner
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

7.  Preferential expansion of V gamma 9 V delta 2 T cells following stimulation of peripheral blood lymphocytes with extracts of Plasmodium falciparum.

Authors:  C Behr; P Dubois
Journal:  Int Immunol       Date:  1992-03       Impact factor: 4.823

8.  Gamma delta T cells and the immune response in visceral leishmaniasis.

Authors:  S Raziuddin; A W Telmasani; M el-Hag el-Awad; O al-Amari; M al-Janadi
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

9.  Antibacterial activity of bovine mammary gland lymphocytes following treatment with interleukin-2.

Authors:  L M Sordillo; M Campos; L A Babiuk
Journal:  J Dairy Sci       Date:  1991-10       Impact factor: 4.034

10.  Analysis of T cells bearing different isotypic forms of the gamma/delta T cell receptor in patients with systemic autoimmune diseases.

Authors:  R Gerli; E Agea; A Bertotto; R Tognellini; L Flenghi; F Spinozzi; A Velardi; F Grignani
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

View more
  4 in total

1.  Bovine gammadelta T-cell responses to the intracellular protozoan parasite Theileria parva.

Authors:  C A Daubenberger; E L Taracha; L Gaidulis; W C Davis; D J McKeever
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Identification of three new bovine T-cell receptor delta variable gene subgroups expressed by peripheral blood T cells.

Authors:  Carolyn T A Herzig; Seth L Blumerman; Cynthia L Baldwin
Journal:  Immunogenetics       Date:  2006-08-01       Impact factor: 2.846

3.  Immunological characterization of a gammadelta T-cell stimulatory ligand on autologous monocytes.

Authors:  Thillainayagam Sathiyaseelan; Brian Naiman; Stefan Welte; Niall Machugh; Samuel J Black; Cynthia L Baldwin
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

4.  Annotation and classification of the bovine T cell receptor delta genes.

Authors:  Carolyn T A Herzig; Marie-Paule Lefranc; Cynthia L Baldwin
Journal:  BMC Genomics       Date:  2010-02-09       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.